Ignite Creation Date:
2025-12-24 @ 7:30 PM
Ignite Modification Date:
2025-12-25 @ 5:11 PM
Study NCT ID:
NCT07169903
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-12
First Post:
2025-06-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT
Sponsor:
Shanghai Pulmonary Hospital, Shanghai, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2033-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-15
First Submit QC Date:
None
Study First Post Date:
2025-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-10
Last Update Post Date:
2025-09-12
Last Update Post Date Type:
ESTIMATED